Advancing Biomarker Validation for Drug Hypersensitivity
Physician's Weekly
JUNE 16, 2025
But the varied mechanisms and clinical presentations of drug hypersensitivity reactions (DHRs) can make diagnosis and treatment challenging, and most biomarkers still require validation. The biomarkers of clinical utility are skin tests , specific IgE (sIgE), tryptase , and some HLA-DR genotyping. The measurement method is described.
Let's personalize your content